Ocuphire Pharma Inc. buy Alliance Global Partners
Start price
20.03.24
/
50%
€1.84
Target price
20.03.25
€18.44
Performance (%)
-16.45%
Price
30.05.24
€1.56
Summary
This prediction is currently active. The prediction for Ocuphire Pharma Inc. disappoints with a performance of -16.45%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Alliance_Global_Part at any time. Alliance_Global_Part has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ocuphire Pharma Inc. | -4.064% | -4.064% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Alliance_Global_Part for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for OCUP provided by MarketBeat